annual cash & cash equivalents:
$890.06M+$372.27M(+71.90%)Summary
- As of today (August 16, 2025), GMED annual cash & cash equivalents is $890.06 million, with the most recent change of +$372.27 million (+71.90%) on December 31, 2024.
- During the last 3 years, GMED annual cash & cash equivalents has risen by +$446.61 million (+100.71%).
- GMED annual cash & cash equivalents is now at all-time high.
Performance
GMED Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$229.45M-$231.82M(-50.26%)Summary
- As of today (August 16, 2025), GMED quarterly cash & cash equivalents is $229.45 million, with the most recent change of -$231.82 million (-50.26%) on June 30, 2025.
- Over the past year, GMED quarterly cash & cash equivalents has dropped by -$180.98 million (-44.10%).
- GMED quarterly cash & cash equivalents is now -70.75% below its all-time high of $784.44 million, reached on December 31, 2024.
Performance
GMED quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMED Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.9% | -44.1% |
| 3 y3 years | +100.7% | +52.2% |
| 5 y5 years | +185.7% | +38.6% |
GMED Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.7% | -70.8% | +70.9% |
| 5 y | 5-year | at high | +185.7% | -70.8% | +70.9% |
| alltime | all time | at high | +696.8% | -70.8% | +452.1% |
GMED Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $229.45M(-50.3%) |
| Mar 2025 | - | $461.27M(-41.2%) |
| Dec 2024 | $890.06M(+71.9%) | $784.44M(+26.0%) |
| Sep 2024 | - | $622.77M(+51.7%) |
| Jun 2024 | - | $410.42M(+15.9%) |
| Mar 2024 | - | $354.06M(-24.2%) |
| Dec 2023 | $517.79M(+16.1%) | $467.29M(+67.1%) |
| Sep 2023 | - | $279.62M(-8.8%) |
| Jun 2023 | - | $306.45M(+40.8%) |
| Mar 2023 | - | $217.69M(+44.7%) |
| Dec 2022 | $446.06M(+0.6%) | $150.47M(+12.1%) |
| Sep 2022 | - | $134.22M(-11.0%) |
| Jun 2022 | - | $150.77M(-34.4%) |
| Mar 2022 | - | $229.79M(+19.0%) |
| Dec 2021 | $443.45M(+3.9%) | $193.07M(-46.6%) |
| Sep 2021 | - | $361.88M(+34.6%) |
| Jun 2021 | - | $268.78M(+45.4%) |
| Mar 2021 | - | $184.85M(-22.8%) |
| Dec 2020 | $426.74M(+37.0%) | $239.40M(-4.5%) |
| Sep 2020 | - | $250.61M(+51.4%) |
| Jun 2020 | - | $165.55M(-0.7%) |
| Mar 2020 | - | $166.74M(-14.8%) |
| Dec 2019 | $311.49M(-8.3%) | $195.72M(+17.8%) |
| Sep 2019 | - | $166.09M(+41.0%) |
| Jun 2019 | - | $117.79M(-9.4%) |
| Mar 2019 | - | $129.98M(-6.9%) |
| Dec 2018 | $339.68M | $139.65M(-3.9%) |
| Sep 2018 | - | $145.29M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $119.94M(+0.1%) |
| Mar 2018 | - | $119.84M(+0.9%) |
| Dec 2017 | $373.71M(+28.5%) | $118.82M(-23.3%) |
| Sep 2017 | - | $154.85M(+3.5%) |
| Jun 2017 | - | $149.67M(-18.0%) |
| Mar 2017 | - | $182.44M(+172.5%) |
| Dec 2016 | $290.79M(-5.3%) | $66.95M(-25.8%) |
| Sep 2016 | - | $90.19M(-5.4%) |
| Jun 2016 | - | $95.34M(+17.3%) |
| Mar 2016 | - | $81.28M(+35.1%) |
| Dec 2015 | $307.15M(+21.8%) | $60.15M(+19.1%) |
| Sep 2015 | - | $50.50M(+21.5%) |
| Jun 2015 | - | $41.56M(-44.6%) |
| Mar 2015 | - | $75.01M(-8.8%) |
| Dec 2014 | $252.07M(+5.5%) | $82.27M(-51.5%) |
| Sep 2014 | - | $169.45M(+24.1%) |
| Jun 2014 | - | $136.50M(+30.5%) |
| Mar 2014 | - | $104.60M(+16.3%) |
| Dec 2013 | $238.92M(+12.5%) | $89.96M(-11.7%) |
| Sep 2013 | - | $101.91M(+10.4%) |
| Jun 2013 | - | $92.31M(-29.8%) |
| Mar 2013 | - | $131.54M(-38.1%) |
| Dec 2012 | $212.40M(+48.9%) | $212.40M(+8.8%) |
| Sep 2012 | - | $195.16M(+17.9%) |
| Jun 2012 | - | $165.58M(+4.1%) |
| Mar 2012 | - | $159.10M(+11.5%) |
| Dec 2011 | $142.67M(+27.7%) | $142.67M |
| Dec 2010 | $111.70M | - |
FAQ
- What is Globus Medical, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
- What is Globus Medical, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
What is Globus Medical, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GMED is $890.06M
What is the all time high annual cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high annual cash & cash equivalents is $890.06M
What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GMED annual cash & cash equivalents has changed by +$372.27M (+71.90%)
What is Globus Medical, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GMED is $229.45M
What is the all time high quarterly cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high quarterly cash & cash equivalents is $784.44M
What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GMED quarterly cash & cash equivalents has changed by -$180.98M (-44.10%)